TLR4- expression, in turn, was correlated with conferring resistance to the drug by promoting anti-apoptotic proteins (159), while IL-6 was found to endorse tumor progression inducing angiogenesis and proliferation via the STAT-3 pathway (160). This evidence concerns the gene IL6 and neoplasm.